Ensign Peak Advisors’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $33.5K | Sell |
|
|||||
|
2024
Q1 | $64.7K | Hold |
|
|||||
|
2023
Q4 | $36.1K | Hold |
|
|||||
|
2023
Q3 | $65.9K | Hold |
|
|||||
|
2023
Q2 | $89.4K | Hold |
|
|||||
|
2023
Q1 | $101K | Hold |
|
|||||
|
2022
Q4 | $92.6K | Hold |
|
|||||
|
2022
Q3 | $271K | Hold |
|
|||||
|
2022
Q2 | $246K | Buy |
|
|||||
|
2022
Q1 | $288K | Hold |
|
|||||
|
2021
Q4 | $221K | Buy |
|